IGF-I treatment of patients with Laron syndrome suppresses serum thrombopoietin levels but does not affect serum erythropoietin.
Orit
Shevah
S
Joanne
Yacobovich
Y
Meira
Zoldan
Z
Hannah
Tamary
T
Zvi
Laron
L
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004921:Erythropoietin / Q000097:blood; D005260:Female; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D046150:Laron Syndrome / Q000097:blood* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D013926:Thrombopoietin / Q000097:blood*
D006133:Growth Substances; D004921:Erythropoietin; D007334:Insulin-Like Growth Factor I; D013926:Thrombopoietin